Parkinson’s disease stops here....

[staceysack]

fascinatetherapeutics.com/

[park_bear]

Passed phase 1a safety study. Some studies of their compound here: scholar.google.com/scholar?...

Will be many years to prove that this works, if it does

[staceysack in reply to park_bear]

Thank you for that. You are very good at researching & it's very helpful for those of us who aren't. I truly appreciate it!

[Smittybear7]

thanks for the information

[Boscoejean]

The structural analog of KM-819, namely N-[1-(4-bromobenzyl)-3,5-dimethyl-1H-pyrazol-4-yl]-2-(phenylsulfanyl) acetamide, served as the internal standard (IS).

phase 2 clinical trial with limited locations

classic.clinicaltrials.gov/...

Locations

United States, California

Parexel Early Phase Clinical Unit Recruiting

Glendale, California, United States, 91206

University California San Diego Medical Center Not yet recruiting

San Diego, California, United States, 92103

United States, Michigan

Quest Research Institute, Rose Cancer Center Enrolling by invitation

Royal Oak, Michigan, United States, 48073

Ages Eligible for Study: 40 Years and older (Adult, Older Adult)

Sexes Eligible for Study: All

Accepts Healthy Volunteers: Yes

Criteria

Inclusion Criteria:

Participant is a healthy volunteer or has a clinical diagnosis of idiopathic Parkinson's disease.

Participant is on a stable dose of medications to treat Parkinson's disease at least 8 weeks prior to randomization

Presence of idiopathic Parkinson's disease Hoehn and Yahr Stage ≤ 4

History or current use of dopamine/dopaminergic drugs, levodopa with decarboxylase inhibitor or dopaminergic agonists, with a stable dosage for at least 30 days prior to Screening

Body mass index (BMI) within the range 18.5 to 35 kg/m2 (inclusive)

and more

[crewmanwhite]

We will stop Parkinson's when companies like this spend as much money on preventing the causes of cell death as they do on blocking cell death.

But there is no profit in people getting well.